IGKV1-27 Antikörper (AA 241-356)
Kurzübersicht für IGKV1-27 Antikörper (AA 241-356) (ABIN7872741)
Target
Alle IGKV1-27 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 241-356
-
Verwendungszweck
- A20 Antibody / TNFAIP3 (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 241-356 from the human protein was used as the immunogen for the A20 antibody.
-
Isotyp
- IgG2c, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the A20 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the A20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- IGKV1-27 (Immunoglobulin kappa Variable 1-27 (IGKV1-27))
-
Andere Bezeichnung
- A20
-
Hintergrund
- A20 (also known as TNFAIP3) is a zinc finger protein and inhibits NF-kappa B activation as well as TNF-mediated apoptosis. The protein has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. A20 is as a tumor suppressor and has been shown to protect MCF-7 breast carcinoma cells from TNF-induced apoptosis. High A20 expression levels were observed in more aggressive breast tumors (ER-negative, progesterone receptor-negative and high histological grade). These findings strongly suggest that A20 is a key protein involved in tamoxifen resistance.
-
UniProt
- P21580
-
Pathways
- Activation of Innate immune Response
Target
-